596
I. González-Temprano et al.
LETTER
(14) Nuclear Overhauser effect difference spectroscopy and 1H-
1H decoupling experiments confirmed the stereochemistry
of isoquinolines. For instance, isoindoloisoquinoline 2a
(Figure 2) demonstrated an enhancement of the H-11, H-12
and H-6ax signals upon irradiation on C-12b methyl
1.25 (m, 2 H), 1.48 (s, 3 H), 1.60–1.72 (m, 6 H), 2.1 (d, J =
8.3 Hz, 1 H), 2.54 (dd, J = 16.2, 4.4 Hz, 1 H), 2.75 (d, J =
13.1 Hz, 1 H), 2.81–2.92 (m, 1 H), 3.07 (ddd, J = 13.1, 12.3,
4.8 Hz, 1 H), 3.21 (d, J = 13.1 Hz, 1 H), 3.32 (d, J = 3.6 Hz,
1 H), 3.37 (s, 1 H), 3.74–3.78 (m, 2 H), 3.81–3.89 (m, 1 H),*
3.82 (s, 3 H),* 3.89 (s, 3 H),* 4.18 (dd, J = 13.1, 6.3 Hz, 1
H), 6.33–6.37 (m, 1 H), 6.45–6.48 (m, 2 H), 6.60 (s, 1 H) (*:
partially overlapped signals); 13C NMR (CDCl3) 19.9, 20.4,
26.5, 27.0, 27.6, 30.5, 35.4, 38.3, 48.7, 44.9, 45.8, 46.5, 48.1,
50.2, 51.0, 52.5, 55.7, 56.2, 60.6, 75.4, 76.8, 107.4, 112.0,
124.1, 135.3, 135.8, 139.2, 147.9, 148.0, 168.4; MS (EI)
m/z (rel. intensity) 526 (M+ + 1, 2), 525 (M+, 1), 373(47),
325(19), 324(23), 310(16), 308(25), 307(100), 292(21),
290(27), 258(26), 206(16), 164(8), 119(35), 91(26).
10a (38 mg, 16%): [ ]D 23 +95.7 (1, CHCl3); IR (CHCl3):
2950, 1780, 1673 cm–1; 1H NMR (CDCl3) 0.86 (s, 3 H), 1.04
(s, 3 H), 1.48 (s, 3 H), 1.23–1.25 (m, 2 H), 1.58–1.92 (m, 5
H), 2.1 (d, J = 8.3 Hz, 1 H), 2.47 (dd, J = 16.0, 3.8 Hz, 1 H),
2.79 (ddd, J = 16.0, 12.3, 6.5 Hz, 1 H), 3.03 (td, J = 12.6, 4.4
Hz, 1 H), 3.12–3.23 (m, 2 H), 3.28 (s, 1 H), 3.52 (d, J = 3.6
Hz, 1 H), 3.59 (s, 1 H), 3.82–3.88 (m, 1 H),* 3.82 (s, 3 H),*
3.89 (s, 3 H),* 4.10 (dd, J = 13.1, 6.1 Hz, 1 H), 5.05 (dd, J =
7.4, 2.8 Hz, 1 H), 6.31–6.34 (m, 1 H), 6.45–6.49 (m, 2 H),
6.60 (s, 1 H) (*: partially overlapped signals); 13C NMR
(CDCl3) 19.6, 20.0, 26.3, 26.7, 27.6, 29.9, 35.7, 38.5, 46.7,
44.8, 45.3, 45.6, 49.2, 50.2, 50.4, 52.6, 55.7, 56.2, 60.7, 75.7,
82.0, 107.6, 111.7, 110.7, 124.0, 135.4, 136.2, 139.7, 147.8,
147.9, 155.6, 169.2; MS (EI) m/z (rel. intensity) 621 (M+, 6),
622 (M + 1, 3), 623 (M + 2, 1), 325(5), 324(100), 308(17),
307(18), 290(12), 258(15), 206(15), 164(13), 135(10),
119(52), 93(11), 91(20).
(8aS,9S,12R,12aS,12bR)-(+)-2,3-Dimethoxy-12b-methyl-
5,6,8a,9,12,12a-hexahydro-9,12-methaneisoindolin[2,3-
a]isoquinolin-8-one(11a). To a solution of 2a (100 mg, 0.2
mmol) in dry THF (5 mL), SmI2 (20 mL of a 0.1 M solution
in THF, 2 mmol), t-BuOH (0.2 mL, 2.1 mmol), and HMPA
(2.5 mL, 15 mmol) were added sequentially at r.t. The
resulting mixture was stirred at this temperature for 1.5 h,
and quenched by the addition of cold HCl (15 mL of a 1 M
solution). The organic layer was separated, and the aqueous
phase was extracted with CHCl3 (3 10 mL). The combined
organic extracts were washed with saturated Na2S2O3 (3 10
mL) and with brine (3 10 mL), dried (Na2SO4) and
concentrated in vacuo. Purification by flash column
hydrogens and vice versa. This fact, together with the
absence of NOE between C-12b methyl hydrogens and the
protons H-12a and H-13, confirms an R configuration for C-
12b. The rest of the NOE experiments carried out were fully
consistent with the proposed stereochemistry in each case.
nOe
nOe
H
6
H
N
O
H
11 H
CH3
12b
10
CH3O
CH3O
1
9 H
H
no
nOe
H
S
R1
O
2a
Figure 2
(15) See ref.9b For other reagents for reductive desulfinylation,
see, for instance: (a) Zn/HOAc: Rusell, G. A.; Mikol, V. J.
Am. Chem. Soc. 1966, 88, 5498. (b) Zn/NH4Cl: Holton, R.
A.; Crouse, D. J.; Williams, A. D.; Kennedy, R. M. J. Org.
Chem. 1987, 52, 2317. (c) Raney Ni/NaPH2O2: Node, M.;
Nishide, K.; Shigeta, Y.; Obata, K.; Shiraki, H.; Kunishige,
H. Tetrahedron 1997, 53, 12883.
(16) The enantiomeric excess of 11a,b and 1a,b was determined
in each case by CSP HPLC (Chiralcel OD, 20% hexane–2-
propanol, 0.4 mL/min) by comparison with the
corresponding racemates. The racemates were prepared by
an alternate procedure described in ref.8b. Representative
procedures and characterization data for 1a, 2a, 10a, 11a:
(8aR,9S,12R,12aS,12bR)-(+)-8a-[(1S,2R,4R,SS)-(2-
Hydroxy-7,7-dimethylbicyclo[2.2.1]heptan-1-
yl)methylsulfinyl]-2,3-dimethoxy-12b-methyl-
5,6,8a,9,12,12a-hexahydro-9,12-methaneisoindolin[2,3-
a]isoquinolin-8-one(2a).
To a solution of the imide 3 (1.15 g, 2.2 mmol) in dry THF
(45 mL), MeLi (7.6 mL of a 0.66 M solution in pentane, 5
mmol) was added at –78 °C. The resulting mixture was
stirred at this temperature for 6 h, quenched by the addition
of saturated NH4Cl (20 mL), and allowed to warm to room
temperature. The organic layer was separated, and the
aqueous phase was extracted with CH2Cl2 (3 20 mL). The
combined organic extracts were dried (Na2SO4) and
concentrated in vacuo to afford hydroxy lactam 9a (1.18 g,
99%), which was used without further purification.
To a solution of the so obtained hydroxy lactam 9a (203 mg,
0.4 mmol) in CH2Cl2 (10 mL), TFA (2.5 mL, 32.4 mmol)
was added and the resulting solution was stirred at room
temperature for 3 days. The reaction mixture was treated
with saturated aqueous NaHCO3, the organic layer was
decanted and the aqueous phase was extracted with CH2Cl2
(3 10 mL). The combined organic extracts were washed
with brine (2 10 mL), dried (Na2SO4) and concentrated in
vacuo. The resulting crude reaction mixture was purified by
column flash chromatography (silica gel, 60% hexane–ethyl
acetate), yielding two fractions.
chromatography (silica gel, ethyl acetate) afforded
isoindoloisoquinoline 11a (59 mg, 96%), whose
spectroscopic data are coincidental to those previously
reported for the racemate8b: [ ]D23 +202.8 (1.43, CHCl3); mp
(Et2O) 183–184 °C [Lit.8a racemate (Et2O) 158–160 °C]; 1H
NMR (CDCl3) 1.45 (s, 3 H),* 1.41–1.45 (m, 1 H),* 1.64 (d,
J = 8.3 Hz, 1 H), 2.44 (d, J = 11.9 Hz, 1 H), 2.96–2.99 (m,
2 H), 3.09–3.11 (m, 2 H), 3.23–3.25 (m, 2 H), 3.82 (s, 3 H),
3.90 (s, 3 H), 4.10–4.14 (m, 1 H), 6.21–6.23 (m, 2 H), 6.48
(s, 1 H), 6.65 (s, 1 H) (*: partially overlapped signals). The
enantiomeric excess was determined by CSP HPLC to be
> 99%, by comparison with the racemic mixture. Chiralcel
OD, 20% hexane–2-propanol, 0.4 mL/min; tr (ent-11a) =
18.5 min (< 1%); tr(11a) = 21.2 min (> 99%).
(10bR)-(+)-(-8,9-Dimethoxy-10b-methyl-5,6-
dihydropyrrolo[2,1-a]isoquinolin-3(10bH)-one(1a).
Isoindoloisoquinoline 11a (92 mg, 0.28 mmol) was heated at
560 °C under vacuum (1 mm Hg) for short periods of time
(10 min).18 The evolution of the reaction was monitored by
1H NMR, and the procedure was repeated until complete
evolution of starting material was observed. The crude
product was purified by column chromatography (silica gel,
80% hexane–EtOAc) (63 mg, 85%), whose spectroscopic
2a (101 mg, 51%): [
]
23 +117.9 (0.5, CHCl3); mp (Et2O–
D
pentane) 121–122 °C; IR (CHCl3): 3400, 2975, 1673, 1407
cm–1; 1H NMR (CDCl3) 0.60 (s, 3 H), 1.04 (s, 3 H), 1.23–
Synlett 2002, No. 4, 593–597 ISSN 0936-5214 © Thieme Stuttgart · New York